Abstract
Sigma1 (also known as this sigma-1 receptor) is an unusual and enigmatic transmembrane protein implicated in a diverse array of biological processes ranging from neurodegenerative disease to cancer. Despite decades of research, the molecular architecture of Sigma1 is only beginning to become clear. Recent work has established that Sigma1 is an oligomer, and crystallographic studies have now offered the first high-resolution views of its molecular structure. For the first time, these results provide a detailed framework to understand mutagenesis data and the molecular pharmacology of Sigma1 ligands. Structural data also raise new questions surrounding the mechanisms of ligand activity and the molecular basis for interactions between Sigma1 and other proteins. As Sigma1 research enters the structural era, the field is poised for new discoveries and reevaluation of old data and old models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akunne HC, Whetzel SZ, Wiley JN, Corbin AE, Ninteman FW, Tecle H, Pei Y, Pugsley TA, Heffner TG (1997) The pharmacology of the novel and selective sigma ligand, PD 144418. Neuropharmacology 36(1):51–62
Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34(3):399–410
Balasuriya D, D’Sa L, Talker R, Dupuis E, Maurin F, Martin P, Borgese F, Soriani O, Edwardson JM (2014) A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF(R)). J Biol Chem 289(46):32353–32363. doi:10.1074/jbc.M114.603506
Ballesteros J, Weinstein H (1995) Integrated methods for modeling G-protein coupled receptors. Methods Neurosci 25:366–428
Caffrey M, Li D, Dukkipati A (2012) Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry 51(32):6266–6288. doi:10.1021/bi300010w
Cassel JA, Daubert JD, DeHaven RN (2005) [(3)H]Alvimopan binding to the mu opioid receptor: comparative binding kinetics of opioid antagonists. Eur J Pharmacol 520(1–3):29–36. doi:10.1016/j.ejphar.2005.08.008
Chae PS, Rasmussen SG, Rana RR, Gotfryd K, Chandra R, Goren MA, Kruse AC, Nurva S, Loland CJ, Pierre Y, Drew D, Popot JL, Picot D, Fox BG, Guan L, Gether U, Byrne B, Kobilka B, Gellman SH (2010) Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods 7(12):1003–1008. doi:10.1038/nmeth.1526
Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330(6007):1091–1095. doi:10.1126/science.1197410
Chung KY, Kim TH, Manglik A, Alvares R, Kobilka BK, Prosser RS (2012) Role of detergents in conformational exchange of a G protein-coupled receptor. J Biol Chem 287(43):36305–36311. doi:10.1074/jbc.M112.406371
Dunwell JM, Culham A, Carter CE, Sosa-Aguirre CR, Goodenough PW (2001) Evolution of functional diversity in the cupin superfamily. Trends Biochem Sci 26(12):740–746
Fan G, Baker ML, Wang Z, Baker MR, Sinyagovskiy PA, Chiu W, Ludtke SJ, Serysheva II (2015) Gating machinery of InsP3R channels revealed by electron cryomicroscopy. Nature 527(7578):336–341. doi:10.1038/nature15249
Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323(5916):934–937
Gromek KA, Suchy FP, Meddaugh HR, Wrobel RL, LaPointe LM, Chu UB, Primm JG, Ruoho AE, Senes A, Fox BG (2014) The oligomeric states of the purified sigma-1 receptor are stabilized by ligands. J Biol Chem 289(29):20333–20344. doi:10.1074/jbc.M113.537993
Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, Weis WI, Okada T, Kobilka BK, Haga T, Kobayashi T (2012) Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482(7386):547–551. http://www.nature.com/nature/journal/v482/n7386/abs/nature10753.html#supplementary-information
Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 93(15):8072–8077
Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596–610
Itzhak Y (1989) Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 36(4):512–517
John CS, Vilner BJ, Bowen WD (1994) Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. J Med Chem 37(12):1737–1739
Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL (2009) Predicting new molecular targets for known drugs. Nature 462(7270):175–181. doi:10.1038/nature08506
Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229(2):553–558
Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien CC, Pasternak GW (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77(4):695–703. doi:10.1124/mol.109.057083
Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E, Green HF, Liu T, Chae PS, Dror RO, Shaw DE, Weis WI, Wess J, Kobilka BK (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482(7386):552–556. http://www.nature.com/nature/journal/v482/n7386/abs/nature10867.html#supplementary-information
Largent BL, Wikstrom H, Gundlach AL, Snyder SH (1987) Structural determinants of sigma receptor affinity. Mol Pharmacol 32(6):772–784
Laurini E, Col VD, Mamolo MG, Zampieri D, Posocco P, Fermeglia M, Vio L, Pricl S (2011) Homology model and docking-based virtual screening for ligands of the sigma1 receptor. ACS Med Chem Lett 2(11):834–839. doi:10.1021/ml2001505
Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ (2014) Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine’s motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther 351(1):153–163. doi:10.1124/jpet.114.216671
Li J, Xu H, Bentley WE, Rao G (2002) Impediments to secretion of green fluorescent protein and its fusion from Saccharomyces cerevisiae. Biotechnol Prog 18(4):831–838. doi:10.1021/bp020066t
Liao M, Cao E, Julius D, Cheng Y (2013) Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature 504(7478):107–112. doi:10.1038/nature12822
Lupardus PJ, Wilke RA, Aydar E, Palmer CP, Chen Y, Ruoho AE, Jackson MB (2000) Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 526(Pt 3):527–539
Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL (1984) Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. J Pharmacol Exp Ther 231(3):539–544
Mishra AK, Mavlyutov T, Singh DR, Biener G, Yang J, Oliver JA, Ruoho A, Raicu V (2015) The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J 466(2):263–271. doi:10.1042/BJ20141321
Moebius FF, Striessnig J, Glossmann H (1997) The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 18(3):67–70
Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR (2015) Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci 127(1):17–29. doi:10.1016/j.jphs.2014.12.005
Ortega-Roldan JL, Ossa F, Amin NT, Schnell JR (2015) Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor. FEBS Lett 589(5):659–665. doi:10.1016/j.febslet.2015.01.033
Ramachandran S, Chu UB, Mavlyutov TA, Pal A, Pyne S, Ruoho AE (2009) The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. Eur J Pharmacol 609(1–3):19–26
Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK (2007) GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 318(5854):1266–1273. doi:10.1126/science.1150609
Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC (2016) Crystal structure of the human sigma1 receptor. Nature 532(7600):527–530. doi:10.1038/nature17391
Seth P, Leibach FH, Ganapathy V (1997) Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 241(2):535–540
Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V (1998) Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 70(3):922–931
Seth P, Ganapathy ME, Conway SJ, Bridges CD, Smith SB, Casellas P, Ganapathy V (2001) Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 1540(1):59–67
Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, Abagyan R, Cherezov V, Liu W, Han GW, Kobayashi T, Stevens RC, Iwata S (2011) Structure of the human histamine H1 receptor complex with doxepin. Nature 475(7354):65–70. doi:10.1038/nature10236
Smith JL, Fischetti RF, Yamamoto M (2012) Micro-crystallography comes of age. Curr Opin Struct Biol 22(5):602–612. doi:10.1016/j.sbi.2012.09.001
Su TP, Su TC, Nakamura Y, Tsai SY (2016) The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci. doi:10.1016/j.tips.2016.01.003
Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC (2013) Structural features for functional selectivity at serotonin receptors. Science 340(6132):615–619. doi:10.1126/science.1232808
Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42(4):355–402
Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE (2013) Structural basis for molecular recognition at serotonin receptors. Science 340(6132):610–614. doi:10.1126/science.1232807
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this chapter
Cite this chapter
Kruse, A. (2016). Structural Insights into Sigma1 Function. In: Kim, F., Pasternak, G. (eds) Sigma Proteins: Evolution of the Concept of Sigma Receptors. Handbook of Experimental Pharmacology, vol 244. Springer, Cham. https://doi.org/10.1007/164_2016_95
Download citation
DOI: https://doi.org/10.1007/164_2016_95
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65851-3
Online ISBN: 978-3-319-65853-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)